Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OIG And CMS Agree Medicaid Needs National Drug Price Benchmark Based On Acquisition Cost

This article was originally published in The Pink Sheet Daily

Executive Summary

With First DataBank scheduled to end publishing average wholesale price data in September, there is an opportunity for states to switch to pharmacy reimbursement based on actual acquisition costs.
Advertisement

Related Content

McKesson Closer To Resolving Multi-Year AWP Legal Saga With $190M Federal Settlement
Medicaid Rx Spend Could Be Cut By Shifting To Actual Acquisition Costs, HHS Suggests
Medicaid Rx Spend Could Be Cut By Shifting To Actual Acquisition Costs, HHS Suggests

Topics

Advertisement
UsernamePublicRestriction

Register

PS072542

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel